The past year was a busy one for the entire Qualisys team of engineers, developers, biomechanists, sales teams and distributors. The company launched an all-new camera platform – Miqus and defined a new Clinical System for human motion analysis, including third party hardware, complying with Medical Device Directive 93/42/EEC.
Qualisys managed to increase sales by more than 40 per cent in the fiscal year ending April 30, which constitutes an important milestone for the company, which now passed 100 MSEK turnover. Although the company entered several new business segments, a majority of the growth came from extremely loyal customers within the core business.
One of the new business segments is Qualisys Sports Performance, in which the world’s most profound running analysis was developed. Combined with an intuitive web report, it enables non-researchers to operate and feedbackrunning and injury preventing advice to runners: http://www.qualisyssports.com/
“I am truly proud of what the entire Qualisys team have achieved over the past year. The bar has been set, we are now going after our next priorities together with our customers and partners” - Henrik Wiberg CEO Qualisys.
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services and has offices in Gothenburg, Chicago and Shanghai.
Our customers are found in the biomechanical research, sports biomechanics and medical sectors. Our systems are also used for engineering and specialized industrial purposes.
Qualisys is certified according to ISO 9001:2015 and compliant with Medical Device Directive 93/42/EEC, which demonstrates our commitment to provide highest possible quality products and services to our customers. The certifications reflect our ongoing investment in technology, process and people.